Abstract #4229
Clinical Evaluation of IVIM and DCE in Sarcoma
Jing Zhang 1 , Pan-Li Zuo 2 , Thorsten Feiweier 3 , and Xiaoguang Cheng 4
1
Beijing Jishuitan Hospital, Beijing,
Beijing, China,
2
Siemens
Healthcare, MR Collaborations NE Asia, Beijing, China,
3
Siemens
Healthcare, Erlangen, Germany,
4
Beijing
Jishuitan Hospital, Beijing, China
The purpose of this study was to assess the clinical
value of IVIM and DCE in sarcoma. 7 patients with
pathologically proven sarcoma were involved in this
study. For IVIM, D-slow was lower in tumor masses than
in healthy muscle, but D-fast and PF had no statistic
difference between them. For DCE, Ktrans, Kep and Ve
were higher in the tumor masses than in healthy muscles
. In sarcoma, ADC and D-slow were able to provide
information about cell growth, and Ktrans provided
information about tumor angiogenesis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
